A great interview in Mad Money On CNBC between Jim Cramer & Regeneron CEO Dr. Leonard Schleifer about #Cancer , $REGN earnings & especially about the future of medicine - #CRISPR & #GeneEditing . “Although #AI is the big thing right now, the real tool is genetics!” #JPM2024 CNBC
1/Prime Medicine has issued a corporate update-as part of its #JPM2024 presentation in which $PRME reported: 1)recent business progress 2) its strategic priorities for 2024 3)presentation of the clinical progress it achieved in 2023 #BioTech #CRISPR #GeneEditing #JPM24 🧵👇
🩺👩🏻⚕️ #JPM2024 started in SF with a 🇫🇷 presence of 30 healthcare startups, led by Lise Alter, CEO of the French Agency for Healthcare Innovation. The occasion to unveil #France2030 healthcare roadmap and explore business opportunities at Business France Healthcare corner.
🧬France is an innovation powerhouse in #Healthcare . 35+ French startups are participing in the SF #JPM2024 Health Care Conference . Today Lise Alter, the French Healthcare Innovation Agency’s CEO, presented the Agency’s strategy to help bring 🇫🇷 innovations to patients worldwide
What a great start to 2024 with #JPM2024 !
🍐Hosted a Lab Coats & Laptops: Life Science and Healthcare Founder Mixer with the best duo, Vera Kutsenko and Helen Kontozopoulos and Pear team @Eddie_Eltoukhy. It was exciting to have our founders visit our new Pear VC SF Studio!
🍐Hosted
We've reached the end of #JPM2024 ! What an amazing week in #SanFrancisco ! I'm so grateful for all the conversations #BioSpace had at #JPM24 . There's an air of optimism regarding #biopharma in 2024. Though it's not all downhill from here, the momentum appears to be gaining.